Martingale Asset Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Martingale Asset Management’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-63,806	Closed	-$404K	–	1051
2019 Q3	$404K	Sell	63,806 -28,022	-31%	-$209K	﹤0.01%	906
2019 Q2	$684K	Hold	91,828	–	–	0.01%	835
2019 Q1	$564K	Buy	91,828 +26,400	+40%	+$306K	0.01%	870
2018 Q4	$754K	Sell	65,428 -2,500	-4%	-$42.7K	0.01%	796
2018 Q3	$1.47M	Buy	67,928 +603	+0.9%	+$11.4K	0.02%	630
2018 Q2	$1.06M	Sell	67,325 -7,700	-10%	-$121K	0.01%	730
2018 Q1	$1.42M	Sell	75,025 -1,200	-2%	-$23.7K	0.02%	644
2017 Q4	$1.33M	Buy	76,225 +9,307	+14%	+$128K	0.02%	648
2017 Q3	$1M	Buy	66,918 +31,501	+89%	+$495K	0.01%	727
2017 Q2	$657K	Buy	35,417 +13,412	+61%	+$233K	0.01%	784
2017 Q1	$372K	Buy	+22,005	New	+$439K	0.01%	850

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Martingale Asset Management's ARA Position: Q4 2019 in Review

Martingale Asset Management sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2019, closing a stake of 63,806 shares — an estimated $404K sold.

Martingale Asset Management first reported a position in ARA in Q1 2017 and held it in 11 quarters. The position peaked at $1.47M in Q3 2018. 66 funds tracked by Wall St. Rank hold ARA as of Q4 2019.

Martingale Asset Management reported no remaining American Renal Associates Holdings, Inc position as of Q4 2019 after selling out during the quarter.
Martingale Asset Management sold 63,806 American Renal Associates Holdings, Inc shares in Q4 2019, an estimated $404K.
Martingale Asset Management first reported a position in American Renal Associates Holdings, Inc in Q1 2017 and held it in 11 quarters.
Martingale Asset Management's American Renal Associates Holdings, Inc position peaked at $1.47M in Q3 2018.
66 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2019.

Based on Martingale Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.